Lorena Bernardo

PhD in Leishmaniasis at Instituto de Salud Carlos III

[CIB Margarita Salas (CSIC) @CIB_CSIC]

Conmemoramos el #8M, Día Internacional de la Mujer, con la campaña #NosotrasSomosCIB, donde ponemos cara a parte de nuestro personal femenino y te contamos en qué trabajan.

[Christopher Fernandez-Prada (He/Him) @PradaCF]

🔬 Our latest study reveals how resistance to antimony and methotrexate in Leishmania infantum could complicate leishmaniasis treatment, signaling a pressing need for new strategies. Dive deeper into our research ➡️ [https://t.co/uxLNIiaUFd] #NTDs #Leishmania #AMR #OneHealth

[Frontiers - Immunology @FrontImmunol]

New Research: Immunosuppressants alter the immune response associated with Glucantime® treatment for Leishmania infantum infection in a mouse model: Background

Immunosuppression is a major risk factor for the development of visceral… https://t.co/IRz76YnvVa #immunology

[Eugenia Carrillo @ecarrilloisciii]

Proud to share the immunological and parasitological results obtained in @WhoccL of the PKDL trial performed in Sudan by @DNDi. Thanks for the invitation to the 28th #leishmaniasis East Africa Platform meeting in Kenya #Leap20

[GEIVEX @GEIVEX]

1st MOVE meeting is being a great success. Thanks to the UMA for a great venue 📷

[Christopher Fernandez-Prada (He/Him) @PradaCF]

#NDouanne from our Lab, in col. with @OlivierMcGill (#GeorgeDong) and @LanglaisLab (@AtiaAmin1), received The 2022 Canadian Network for NTDs Award for Outstanding
Canadian NTDs Research Paper. https://t.co/blxgFHoOPP @UMontreal @Can_NTDs @CellReports @CIHR_IRSC @CAGH_ACSM 🥳🥳🥳

[Lorena Bernardo @Lorena_LBB]

@biataha5 @WhoccL @SaludISCIII @Semtsies @ciberinfec @RICETropicales @LeishSpain @GLeishmania @BiologiaUcm Thank you very much Taha 😊

[Lorena Bernardo @Lorena_LBB]

@AEstadea @WhoccL @SaludISCIII @ecarrilloisciii @ffarmaciaUCM Thank you!

[Lorena Bernardo @Lorena_LBB]

@OlivierMcGill @WhoccL @SaludISCIII @ecarrilloisciii @ffarmaciaUCM Thank you! 😀

[Lorena Bernardo @Lorena_LBB]

@biataha5 @WhoccL @SaludISCIII @ecarrilloisciii @ffarmaciaUCM Thank you very much Taha 😊

[Lorena Bernardo @Lorena_LBB]

@PradaCF @WhoccL @SaludISCIII @ecarrilloisciii @ffarmaciaUCM Thank you so much! 😊

[Lorena Bernardo @Lorena_LBB]

@biataha5 @WhoccL @tahabia1 @SaludISCIII @ciberinfec @Semtsies Congratulations Taha! 👏🏼

[Peter Olbrich @petolb_huvr]

@Lorena_LBB @WhoccL Congratulations to this great and important work! 🎉

[Lorena Bernardo @Lorena_LBB]

@petolb_huvr @WhoccL Thank you very much @petolb_huvr ! Here (https://t.co/bMgnG5W1qA) you can find the first results we have published about immunosuppressive treatments. The ones regarding mtx resistance will be published soon.

[Instituto de Salud Carlos III (ISCIII) @SaludISCIII]

Investigadores del #ISCIII, del Laboratorio de Leishmaniasis @WhoccL, participan esta semana en el congreso @WLeish7, una de las citas más relevantes en el estudio de esta enfermedad.
#worldleish7

[WorldLeish7 @WLeish7]

Can you believe it!!??😱 #Worldleish7

[Christopher Fernandez-Prada (He/Him) @PradaCF]

Is there any potential link between #immunosupression and #drugresistance in #Leishmania⁉️ Come visit @Lorena_LBB at poster P2-020 (423) at @WLeish7 and discover our last findings in collaboration with @WhoccL

[Christopher Fernandez-Prada (He/Him) @PradaCF]

I will be presenting CFP-Lab last piece of work (https://t.co/pPQd8BQZG6) on Thursday 4 at @WLeish7 @PecetColombia

Do you want to discuss about #extracellularvesicles #geneticexchange #drugresistance #genomics and #Leishmania? See you all there!

[Christopher Fernandez-Prada (He/Him) @PradaCF]

We are very excited of sharing our last piece of work: Leishmania parasites exchange drug-resistance genes through extracellular vesicles https://t.co/tanNoca0fa #parasites #leishmania @CellReports @TrendsParasitol @CellCellPress @Can_NTDs @OlivierMcGill @UMontreal

[Instituto de Salud Carlos III (ISCIII) @SaludISCIII]

📍 Una revisión sobre una familia de proteínas de los parásitos que causan la leishmaniasis, publicada por investigadores del #ISCIII y el @CBMSO_CSIC_UAM, aporta información que puede facilitar la búsqueda de nuevos tratamientos.

📰 #NoticiasISCIII ➡️ https://t.co/MopJUmogMd